Vitamin D3 for Life

Live Enlightened

Research libraryVitamin D3 For Life
Study design and methods

Primary relevance to vitamin D Vitamin D is a stated subject of this paper.

Vitamin D is a stated subject of this paper; the supporting source evidence is shown below.

Why this paper is included

Supporting source evidence:

Ukrainian Consensus on Diagnosis and Management of Vitamin D Deficiency in Adults

Source: Article title. View original paper

Relevance classification does not establish study quality, causation or editorial approval.

Study design Review / evidence synthesis.

Review / evidence synthesis

Reviews existing research; the exact review methods need further assessment.

Meta-analysis unclear · Blinding not applicable to this review · Research setting awaiting verification

How this paper was classified

Automatic source-based classification; awaiting editorial verification. This is not a quality score.

Publisher article type: review-article

Source: Publisher publication metadata.

View supporting evidence in the original paper

What the study types mean
Systematic review
Uses explicit methods to identify, assess and summarise research on a defined question.
Scoping review
Maps the extent and characteristics of research on a topic.
Narrative review
Discusses existing research; systematic-review methods have not been established by this classification.
Review / evidence synthesis
Reviews existing research; the exact review methods need further assessment.
Randomised controlled trial
Assigns participants or groups to comparison interventions by chance.
Non-randomised intervention study
Examines an intervention without random allocation.
Cohort study
Examines exposures and outcomes over time within a defined group.
Case-control study
Compares people with an outcome against people without it, examining exposures.
Cross-sectional study
Examines a population at a particular point in time.
Observational study
Observes exposures and outcomes without assigning the exposure; the subtype is not established here.
Case report
Describes an individual case.
Case series
Describes a group of individual cases.
Secondary analysis
Analyses existing study data; this paper is not automatically another independent trial.
Laboratory study
Investigates biological processes in a laboratory setting.
Qualitative study
Examines experiences or meanings using qualitative methods.
Genetic instrumental-variable study
Uses genetic variation as an instrument to investigate relationships; this is not a randomised treatment trial.
Study protocol
Describes planned methods and is not evidence that the planned study has reported results.
Multiple reported designs
More than one design is explicitly reported; examine the supporting methods.
Study design awaiting verification
The available source does not establish a sufficiently clear study design.

Meta-analysis combines numerical results from studies. Blinding describes who was unaware of treatment allocation. Neither is a separate quality grade. Study design, vitamin D relevance and document format are independent filters.

Abstracts

Ukrainian Consensus on Diagnosis and Management of Vitamin D Deficiency in Adults

Review / evidence synthesis · Nutrients · 2024

Original publication title

Ukrainian Consensus on Diagnosis and Management of Vitamin D Deficiency in Adults

Nataliia Grygorieva; Mykola Tronko; Volodymir Kovalenko; Serhiy Komisarenko; Tetiana Tatarchuk; Ninel Dedukh; Mykola Veliky; Serhiy Strafun; Yulia Komisarenko; Andrii Kalashnikov; Valeria Orlenko; Volodymyr Pankiv; Oleg Shvets; Inna Gogunska; Svitlana Regeda

© 2024 by the authors.

Original publication · Publisher record · CC BY 4.0

Source wording retained. Formatting, section navigation and display-title punctuation adapted for this research record.

At a glance

What does the authors’ abstract report?

Vitamin D deficiency (VDD) is a global problem, however, there were no Ukrainian guidelines devoted to its screening, prevention, and treatment, which became the reason for the Consensus creation. This article aimed to present the Consensus of Ukrainian experts devoted to VDD management. Following the creation of the multidisciplinary Consensus group, consent on the formation process, drafting and fine-tuning of key recommendations, and two rounds of voting, 14 final recommendations were successfully voted upon. Despite a recent decrease in VDD prevalence in Ukraine, we recommend raising awareness regarding VDD’s importance and improving the strategies for its decline.

We recommend screening the serum 25-hydroxyvitamin D (25(OH)D) level in risk groups while maintaining a target concentration of 75 to 125 nmol/L (30 to 50 ng/mL). We recommend prophylactic cholecalciferol supplementation (800 to 2000 IU/d for youthful healthy subjects, and 3000 to 5000 IU/d for subjects from the risk groups). For a VDD treatment, we recommend a short-term administration of increased doses of cholecalciferol (4000 to 10,000 IU/d) with 25(OH)D levels monitored after 4 to 12 weeks of treatment, followed by the use of maintenance doses. Additionally, we recommend assessing serum 25(OH)D levels before antiosteoporotic treatment and providing vitamin D and calcium supplementation throughout the full course of the antiosteoporotic therapy.

Authors’ abstract

Vitamin D deficiency (VDD) is a global problem, however, there were no Ukrainian guidelines devoted to its screening, prevention, and treatment, which became the reason for the Consensus creation. This article aimed to present the Consensus of Ukrainian experts devoted to VDD management. Following the creation of the multidisciplinary Consensus group, consent on the formation process, drafting and fine-tuning of key recommendations, and two rounds of voting, 14 final recommendations were successfully voted upon. Despite a recent decrease in VDD prevalence in Ukraine, we recommend raising awareness regarding VDD’s importance and improving the strategies for its decline.

We recommend screening the serum 25-hydroxyvitamin D (25(OH)D) level in risk groups while maintaining a target concentration of 75 to 125 nmol/L (30 to 50 ng/mL). We recommend prophylactic cholecalciferol supplementation (800 to 2000 IU/d for youthful healthy subjects, and 3000 to 5000 IU/d for subjects from the risk groups). For a VDD treatment, we recommend a short-term administration of increased doses of cholecalciferol (4000 to 10,000 IU/d) with 25(OH)D levels monitored after 4 to 12 weeks of treatment, followed by the use of maintenance doses. Additionally, we recommend assessing serum 25(OH)D levels before antiosteoporotic treatment and providing vitamin D and calcium supplementation throughout the full course of the antiosteoporotic therapy.

Publication and source details

Original title: Ukrainian Consensus on Diagnosis and Management of Vitamin D Deficiency in Adults

Nataliia Grygorieva; Mykola Tronko; Volodymir Kovalenko; Serhiy Komisarenko; Tetiana Tatarchuk; Ninel Dedukh; Mykola Veliky; Serhiy Strafun; Yulia Komisarenko; Andrii Kalashnikov; Valeria Orlenko; Volodymyr Pankiv; Oleg Shvets; Inna Gogunska; Svitlana Regeda

Nutrients · 2024

* Correspondence: crystal_ng@ukr.net; Tel.: +380-(44)-3556060© 2024 by the authors.2024https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).The authors declare no financial support in the Consensus creation and preparation of the article. The work of the expert group was initiated and coordinated with the non-financial support of the Ukrainian Osteoporosis Association.

Repository JATS snapshot; version as supplied

Source retrieved: 2026-11-11T05:21:20.178368+00:00

DOI: 10.3390/nu16020270 · PMC10820145